Austin’s NarrativeDx Adds $1.1M for Hospital-Improvement A.I. Tool

Austin—NarrativeDx, a startup whose software helps hospitals analyze patient feedback to improve or prevent problems related to their experiences, has added about $1.1 million in an equity financing, according to a federal securities filing.

The Austin, TX-based company says it uses natural language processing and machine learning software to collect and analyze patient feedback about their hospital visit, both information given directly to the hospital and through other sources, such as online reviews, social media, hospital surveys, and grievance letters. NarrativeDx says its dashboard will automatically highlight specific ways the hospital can improve.

The company was founded in 2013 by Kyle Robertson, a lawyer and computer engineer, and Senem Guney, who has a doctorate in organizational communication and technology. NarrativeDx landed a Series A round of funding a year ago, which was led by LiveOak Venture Partners, Cultivation Capital, and HealthX Ventures. Though the amount wasn’t announced publicly, the company raised about $3.7 million, according to a filing with the Securities and Exchange Commission. Silverton Partners and Floodgate have also invested in the company, according to Robertson’s LinkedIn profile.

NarrativeDx’s customers include San Mateo Medical Center in California and Rusk Rehabilitation at NYU Langone Health in New York, according to quotes on the company’s website.

Robertson and Guney haven’t responded for a request for comment.

Author: David Holley

David is the national correspondent at Xconomy. He has spent most of his career covering business of every kind, from breweries in Oregon to investment banks in New York. A native of the Pacific Northwest, David started his career reporting at weekly and daily newspapers, covering murder trials, city council meetings, the expanding startup tech industry in the region, and everything between. He left the West Coast to pursue business journalism in New York, first writing about biotech and then private equity at The Deal. After a stint at Bloomberg News writing about high-yield bonds and leveraged loans, David relocated from New York to Austin, TX. He graduated from Portland State University.